## CBOE: Cboe Global Markets, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: PEG 2.09 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($243.05)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Cboe Global Markets (CBOE) Valuation After Barclays Upgrade on Derivatives Growth and Strategic Refocus**
- Source: Simply Wall Street | 20251216T140812 | Somewhat-Bullish | Relevance: 100%
- Barclays upgraded Cboe Global Markets (CBOE) to Overweight, citing strong performance in its index options and increased retail options activity. Despite a robust share price run and near-record highs, the company's valuation is debated, with Simply Wall St's narrative suggesting it's 5.8% undervalued, whereas a DCF model indicates it's overvalued. The article highlights Cboe's consistent double-digit revenue growth in its Data Vantage segment and strategic refocus on core derivatives.

**2. Cboe Global Markets (CBOE) Valuation After Barclays Upgrade on Derivatives Growth and Strategic Refocus**
- Source: Simply Wall Street | 20251216T140119 | Somewhat-Bullish | Relevance: 100%
- Barclays upgraded Cboe Global Markets (CBOE) to Overweight, citing its strong index options engine, increased retail options activity, and a sharpened focus on core derivatives. Despite a strong performance year-to-date and near-record highs, the stock's valuation is a key debate, showing a narrative fair value of $262.08 (moderately undervalued) versus a DCF model's $201 (overvalued). The narrative emphasizes Cboe's double-digit revenue growth in Data Vantage and operational efficiencies, while the DCF model suggests potential overvaluation if growth or margins underperform.

**3. Europe Equities Trade Reporting Services | Cboe**
- Source: Cboe Global Markets | 20251217T060759 | Somewhat-Bullish | Relevance: 100%
- Cboe Europe offers BXTR, a suite of Trade Reporting Services designed to standardize OTC data and help firms meet regulatory requirements under MiFID II. This includes on-exchange and OTC reporting, dissemination of MTF trades, and pre-trade transparency quoting. The article details the steps for new and existing participants to go live with the services, covering documentation, connectivity, and testing.

**4. Thrivent Financial for Lutherans Has $27.24 Million Position in Cboe Global Markets, Inc. $CBOE**
- Source: MarketBeat | 20251216T135219 | Neutral | Relevance: 100%
- Thrivent Financial for Lutherans significantly increased its stake in Cboe Global Markets, Inc. (NASDAQ:CBOE) by 44.3% in the second quarter, now owning 116,859 shares valued at $27.24 million. This move comes as Cboe Global Markets reported strong quarterly earnings, beating consensus estimates with an EPS of $2.67 and a 13.8% year-over-year revenue increase. The company also recently paid a quarterly dividend of $0.72 per share, and analysts maintain a "Hold" rating with an average target price of $245.15 for the stock.

**5. DeFi Technologies Announces Launch of Brazilian Depositary Receipts for Institutional Investors on B3 Exchange**
- Source: PR Newswire | 20251215T220902 | Somewhat-Bullish | Relevance: 65%
- DeFi Technologies has received approval from the B3 Exchange to list Brazilian Depositary Receipts (BDRs) for its common shares under the ticker DEFT31, expected to begin trading on December 17, 2025. This strategic move aims to expand DeFi Technologies' visibility and institutional investor base in Brazil, complementing its existing Nasdaq listing and reinforcing its international expansion. The BDRs will provide Brazilian institutional investors with local, BRL-denominated exposure to DeFi Technologies' common shares through their existing brokerage and custody rails.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | Barclays | $302 | $273 | +11% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | Barclays | up | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 1 ($0.00M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 11.5% (+0.0%)
- Blackrock Inc.: 9.0% (-2.7%)
- Alliancebernstein L.: 6.1% (-31.2%)
- State Street Corpora: 4.5% (+2.1%)
- FMR, LLC: 4.3% (+62.1%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_10 improving +4.8% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.09 elevated, pricing in significant growth expectations. Forward P/E 23.2x stretched relative to 5% growth. Quality metrics strong (ROE 22%, margin 21%). Analyst sentiment positive (1 raises, avg +11%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $26.4B |
| Beta | 0.35 |
| 52W Range | $187.30 - $262.98 |
| Short Interest | 3.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.09 |
| Forward P/E | 23.2 |
| Current P/E | 24.3 |
| YoY Growth | 5.1% |
| EPS Direction | RISING |

### Technicals

MRS_10 strengthening from -1.4% to 3.4% (+4.8% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 63rd percentile. MRS_5 at 2.8% confirms short-term momentum alignment. Long-term uptrend intact (above SMA200 at 1.08x) but short-term weakness (below SMA20). MACD histogram bearish (-0.88), momentum weakening. RSI neutral at 51. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.36% (CS: 64) | Strong |
| RSI_14 | 51.4 | Neutral |
| MACD Histogram | -0.88 | Bearish |
| vs SMA20 | 0.997x | Below |
| vs SMA50 | 1.016x | Above |
| vs SMA200 | 1.077x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $252.73
- **Stop Loss:** $243.05 (3.8% risk)
- **Target:** $262.41 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 111
- **Position Value:** $28,053.03
- **Portfolio %:** 28.05%
- **Risk Dollars:** $1,080.00
- **Risk Per Trade:** 1.08%
- **Modifiers:** L1 90% | L2 120% | Combined 1.08x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_OFF (HIGH) | 0.90x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*RISK_OFF regime with deteriorating conditions. VIX rising to 17.6 (+11.7% over 5 days) signals increasing anxiety, while narrow breadth at 52.6% indicates selective participation. AI infrastructure cost concerns are pressuring tech leadership, creating sector rotation challenges in a late-cycle environment.*

### Earnings

**Next:** 2026-02-06 (Est: $2.73)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.53 | $2.67 | +5.6% |
| 2025Q2 | $2.44 | $2.46 | +0.6% |
| 2025Q1 | $2.36 | $2.50 | +5.8% |
| 2024Q4 | $2.12 | $2.10 | -0.9% |

---
*RULE-based L3 | 2026-01-07 01:40 | MRS_10*